Neuren Pharmaceuticals Ltd
F:NK9
Neuren Pharmaceuticals Ltd
F:NK9
Price:
8.2
EUR
-0.61%
Market Closed
Market Cap:
€1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neuren Pharmaceuticals Ltd
F:NK9
|
AU |
|
Jyske Bank A/S
CSE:JYSK
|
DK |
|
E
|
Eventbrite Inc
SWB:EB4
|
US |
|
T
|
Thai Vegetable Oil PCL
SET:TVO
|
TH |
|
M
|
Microchip Technology Inc
SWB:MCP
|
US |
|
H
|
HanaTour Service Inc
LSE:TOUR
|
KR |
|
E
|
Elmet Group Co
NASDAQ:ELMT
|
US |
|
N
|
News Corp
SWB:NC0E
|
US |
|
J
|
Japan Post Bank Co Ltd
SWB:5JP
|
JP |
|
Jabil Inc
NYSE:JBL
|
US |
|
A
|
Andritz AG
XHAM:AZ2
|
AT |
|
D
|
De La Rue PLC
XBER:DL1C
|
UK |
|
4
|
4Basebio PLC
F:88Q
|
UK |
|
Sobha Ltd
BSE:532784
|
IN |
|
Castile Resources Ltd
ASX:CST
|
AU |
|
C
|
CLEANTEK Industries Inc
OTC:GLKFF
|
CA |
Multiples-Based Value
The Multiples-Based Value for 
Neuren Pharmaceuticals Ltd (NK9) under the Base Case is hidden
EUR.
Compared with the current market price of 8.2 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NK9 Multiples-Based Value
LOCKED
